Chapter 334 Functional Abdominal Pain (Nonorganic Chronic Abdominal Pain)
Recurrent abdominal pain (RAP) in children was defined as at least 3 episodes of pain over at least 3 mo that interfered with function. In many situations the term recurrent abdominal pain was used synonymously with functional abdominal pain. Other terms such as chronic abdominal pain, nonorganic abdominal pain, and psychogenic abdominal pain that were used for describing abdominal pain in children led to clinical confusion. The American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain and the North American Society for Pediatric Gastroenterology Hepatology and Nutrition Committee on Abdominal Pain suggested that RAP no longer be used. The recommended clinical definitions for long-lasting intermittent or constant abdominal pain by the same committees are outlined in Table 334-1.
Table 334-1 RECOMMENDED CLINICAL DEFINITIONS OF LONG-STANDING INTERMITTENT OR CONSTANT ABDOMINAL PAIN IN CHILDREN
DISORDER | DEFINITION |
---|---|
Chronic abdominal pain | Long-lasting intermittent or constant abdominal pain that is functional or organic (disease based) |
Functional abdominal pain | Abdominal pain without demonstrable evidence of pathologic condition, such as anatomic metabolic, infectious, inflammatory or neoplastic disorder. Functional abdominal pain can manifest with symptoms typical of functional dyspepsia, irritable bowel syndrome, abdominal migraine or functional abdominal pain syndrome. |
Functional dyspepsia | Functional abdominal pain or discomfort in the upper abdomen |
Irritable bowel syndrome | Functional abdominal pain associated with alteration in bowel movements |
Abdominal migraine | Functional abdominal pain with features of migraine (paroxysmal abdominal pain associated with anorexia, nausea, vomiting or pallor as well as maternal history of migraine headaches) |
Functional abdominal pain syndrome | Functional abdominal pain without the characteristics of dyspepsia, irritable bowel syndrome, or abdominal migraine. |
Adapted from Di Lorenzo C, Colletti RB, Lehmann HP, et al; American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain; NASPGHAN Committee on Abdominal Pain: Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, J Pediatr Gastroenterol Nutr 40(3):245–248, 2005.
Chronic abdominal pain can be organic or nonorganic, depending on whether a specific etiology is identified. Nonorganic abdominal pain or functional abdominal pain refers to pain without evidence of anatomic, inflammatory, metabolic, or neoplastic abnormalities. Functional gastrointestinal disorders (FGIDs) are a group of gastrointestinal (GI) disorders that include variable combinations of chronic or recurrent GI symptoms not explained by structural or biochemical abnormalities. The Rome Committee updates and modifies the information on FGIDs for clinical and research purposes. The Rome III process had 2 pediatric subcommittees based on age range: Neonate/Toddler (0-4 yr) and Child/Adolescent (4-18 yr). The Child/Adolescent committee categorized abdominal pain-related FGIDs under Category H2 in Table 334-2. The Rome III criteria for the diagnosis of Childhood Functional Abdominal Pain (category H2d) and Childhood Functional Abdominal Pain Syndrome (category H2d1) is represented in Table 334-3.
Table 334-2 CHILDHOOD FUNCTIONAL GI DISORDERS: CHILD/ADOLESCENT (CATEGORY H)
Adapted from Rome Foundation: Rome III disorders and criteria (website). www.romecriteria.org/criteria/. Accessed May 7, 2010.
Table 334-3 ROME III CRITERIA FOR CHILDHOOD FUNCTIONAL ABDOMINAL PAIN H2D AND CHILDHOOD FUNCTIONAL ABDOMINAL PAIN SYNDROME H2D1
H2d. CHILDHOOD FUNCTIONAL ABDOMINAL PAIN
Diagnostic criteria* must include all of the following:
H2d1. CHILDHOOD FUNCTIONAL ABDOMINAL PAIN SYNDROME
Diagnostic criteria* must satisfy criteria for childhood functional abdominal pain and have at least 25% of the time one or more of the following:
FGID, functional gastrointestinal disorder.
* Criteria fulfilled at least once per week for ≥2 mo prior to diagnosis
Adapted from Rome Foundation: Rome III disorders and criteria (website). www.romecriteria.org/criteria/. Accessed May 7, 2010.
Evaluation and Diagnosis
While evaluating a patient with chronic abdominal pain, distinguishing organic pain and functional pain can be challenging. A wide range of potential organic causes of chronic abdominal pain (see Table 298-13) must be considered before establishing a diagnosis of functional pain (nonorganic). Frequently cited causes of chronic abdominal pain include constipation, esophagitis, gastritis, inflammatory bowel disease, and possibly giardiasis. There is little evidence that the frequency, severity, or location of the pain helps to distinguish between organic and nonorganic pain. It is controversial whether nighttime awakening due to pain is concerning for organic disorders or if it can be seen with functional pain syndromes.
A through history and physical examination would identify the alarm symptoms and signs (Tables 334-4 and 334-5). The presence of alarm symptoms and signs warrants further investigation. The absence of alarm symptoms and signs, a normal physical examination, and a normal stool hemoccult test is sufficient for an initial diagnosis of functional abdominal pain. The laboratory, radiologic, or endoscopic approach to children with chronic abdominal pain should be individualized, depending on the findings suggested by a detailed history and physical examination.
Table 334-4 ALARM SYMPTOMS USUALLY NEEDING FURTHER INVESTIGATIONS
Treatment
Treatment goals should be set for return to function and minimizing pain. Complete disappearance of pain would be an unreasonable goal to set. Cognitive-behavioral therapy is helpful in the short term for managing pain and functional disability (Table 334-6). Biofeedback, guided imagery, and relaxation techniques have been useful in some children with functional pain. Even though studies have not shown consistent benefits from medications, time-limited use of medications is usually part of the multidisciplinary approach. The commonly used medications include acid suppressants for dyspepsia symptoms, antispasmodics, and low-dose amitriptyline. For chronic abdominal pain with IBS symptoms, antidiarrheals and nonstimulating laxatives are used. Peppermint oil for 2 wk improves IBS symptoms in children. There is no evidence that lactose-restricted diet and fiber supplements decrease the frequency of attacks in chronic abdominal pain in children. Proton pump inhibitors or visceral muscle relaxants (anticholinergics) have been used empirically but are often unhelpful in the absence of specific indication.
Table 334-6 EFFECTIVENESS OF TREATMENTS FOR ABDOMINAL PAIN IN CHILDREN
THERAPY | DEFINITION OF DISORDER | EFFECTIVENESS |
---|---|---|
Cognitive behavioral (family) therapy | Recurrent abdominal pain | Beneficial |
Famotidine | Recurrent abdominal pain and dyspeptic symptoms | Inconclusive |
Added dietary fiber | Recurrent abdominal pain | Unlikely to be beneficial |
Lactose-free diet | Recurrent abdominal pain | Unlikely to be beneficial |
Peppermint oil | Irritable bowel syndrome | Likely to be beneficial |
Amitriptyline | Functional GI disorders, Irritable bowel syndrome | Inconsistent results |
Lactobacillus GG | Irritable bowel syndrome using Rome II criteria | Unlikely to be beneficial |
The effectiveness of analgesics, antispasmodics, sedatives, and antidepressants is currently unknown.
GI, gastrointestinal.
From Berger MY, Gieteling MJ, Benninga MA: Chronic abdominal pain in children, BMJ 334:997–1002, 2007.
American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain and NASPGHAN Committee on Abdominal Pain. Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediat Gastroenteol Nutr. 2005;40:245-248.
American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain and NASPGHAN Committee on Abdominal Pain. Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediat Gastroenteol Nutr. 2005;40:249-261.
American College of Gastroenterology IBS Task Force. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104:S1-S35.
Apley J. The child with recurrent abdominal pain. Pediatr Clin North Am. 1967;14:63-72.
Bahar RJ, Collins BS, Steinmetz B, et al. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152:685-689.
Berger MY, Gieteling MJ, Benninga MA. Chronic abdominal pain in children. BMJ. 2007;334:997-1002.
Bijkerk CJ, de Wit NJ, Muris JWM, et al. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomized placebo controlled trial. BMJ. 2009;339:613-615.
Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100:1868.
Faure C, Wieckowska A. Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr. 2007;150:66-71.
Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome. Arch Intern Med. 2009;169:651-658.
Ford AC, Talley NJ, Spiegel BMR, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:1388-1390.
Ford AC, Talley NJ, Veldenhuyzen van Zanten SJO, et al. Will the history and physical examination help establish that irritable bowel syndrome is causing the patient’s lower gastrointestinal tract symptoms? JAMA. 2008;300:1793-1804.
Ghandour RM, Overpeck MD, Huang ZJ, et al. Headache, stomachache, backache, and morning fatigue among adolescent girls in the United States: associations with behavioral, sociodemographic, and environmental factors. Arch Pediatr Adolesc Med. 2004;158:797-803.
Halac U, Noble A, Faure C. Rectal sensory threshold for pain is a diagnostic marker of irritable bowel syndrome and functional abdominal pain in children. J Pediatr. 2010;156:60-65.
Huertas-Ceballos A, Logan S, Bennett C, Macarthur C: Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood (review), Cochrane Database Sys Rev (1):CD003019, 2009.
Hyman PE, Monagas J. Rectal perceptual hypersensitivity: a biomarker for pediatric irritable bowel syndrome. J Pediatr. 2010;156:5-6.
Lane MM, Weidler EM, Czyzewski DI, et al. Pain symptoms and stooling patterns do not drive diagnostic costs for children with functional abdominal pain and irritable bowel syndrome in primary or tertiary care. Pediatrics. 2009;123:758-764.
Mayer EA. Irritable bowel syndrome. N Engl J Med. 2008;358:1692-1698.
Nurko S. The tip of the iceberg: the prevalence of functional gastrointestinal diseases in children. J Pediatr. 2009;154:313-315.
Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):501-512.
Rome Foundation. Rome III disorders and criteria. (website) www.romecriteria.org/criteria Accessed May 7, 2010
Saps M, Seshadri R, Sztainberg M, et al. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr. 2009;154:322-326.
Saps M, Youseff N, Miranda A, et al. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137:1261-1269.
Scarpellini E, Giorgio V, Gabrielli M, et al. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr. 2009;155:416-420.
Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):514-522.